Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients

This study prospectively evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in a cohort of non-electively hospitalized older (> 70 years) adults with cancer.

Studieoversigt

Detaljeret beskrivelse

This study evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in non-electively hospitalized older (> 70 years) adults with cancer. Participants will be randomly assigned to the GARRT group, or the control group. All participants will fill out user friendly questionnaire called the geriatric assessment. The results of the geriatric assessment will be given to the physicians of participants in the GARRT group in real-time. The physicians of participants in the control group will not receive real time results.

This study will compare the referral rates of participants in each group to determine if providing real-time results of the geriatric assessment impact referral rates.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

148

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • North Carolina
      • Chapel Hill, North Carolina, Forenede Stater, 27599
        • UNC Lineberger Comprehensive Cancer Center

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

70 år og ældre (Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Age 70 years or older.
  • English speaking.
  • Admitted to UNC Hospitals non-electively within 72 hours.
  • Biopsy proven solid tumor or myeloma or lymphoma.
  • Newly diagnosed cancer patients for whom active cancer directed therapy is planned within the next six months or patients on active cancer directed therapy either currently or within the previous 6 months.
  • Signed written IRB-approved informed consent.

Exclusion Criteria:

  • Patients meeting any of the following exclusion criteria at baseline will be excluded from study participation. Patients with a life expectancy <6 weeks
  • Patients who are <48 hours post-surgery.
  • Patients who are admitted to an intensive care setting.
  • Patients with acute myeloma lymphoma (AML) or other high grade hematologic malignancies.
  • Patients undergoing bone marrow transplant or admitted to the bone marrow transplant unit.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: GARRT Arm
Participants in this arm complete an brief geriatric assessment, and the results of these assessments are given to providers with recommendations to address deficits identified by the geriatric assessment
Providers will receive results of the brief geriatric assessment with recommendations for address deficits identified through the results of the brief geriatric assessment
Aktiv komparator: Control Arm
Providers of participants of this group will not receive the results of the brief geriatric assessments. These participants will receive standard of care treatment
Providers will not receive results of the brief geriatric assessment. Participants will receive standard of care treatment

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Referral rate for GA-identified deficits in intervention and control groups
Tidsramme: 2 years
Number of participants with at least one referral for a GA-idenfied deficit
2 years

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Referral to Physical and Occupational therapy
Tidsramme: 2 years
Number of times physical and occupation therapy referral was given in Intervention and Control group
2 years
Referral to Geriatic Consultation
Tidsramme: 2 years
Number of times a Geriatric Consultation referral was given in Intervention and Control group
2 years
Referral to Clinical Pharmacist
Tidsramme: 2 years
Number of times Clinical Pharmacist referral was given in Intervention and Control group
2 years
Referral to Nutritionist
Tidsramme: 2 years
Number of times Nutritionist referral was given in Intervention and Control group
2 years
Referral to psyhcosocial support team
Tidsramme: 2 years
Number of times psychosocial support referral was given in Intervention and Control group
2 years
Physician Reported New information
Tidsramme: 2 years
Number of times physicians answer "yes" to the questions "did report provide new information about patient deficits that would warrant a referral"
2 years
Physician Reported Satisfaction
Tidsramme: 2 years
Number of times physician indicate "yes" report was helpful when asked "Is this report useful"
2 years

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Trevor Jolly, MBBS, UNC Lineberger Comprehensive Cancer Center

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

25. april 2016

Primær færdiggørelse (Faktiske)

24. april 2018

Studieafslutning (Faktiske)

24. april 2018

Datoer for studieregistrering

Først indsendt

13. maj 2019

Først indsendt, der opfyldte QC-kriterier

14. maj 2019

Først opslået (Faktiske)

15. maj 2019

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

15. maj 2019

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

14. maj 2019

Sidst verificeret

1. maj 2019

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • LCCC 1538

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner